FMR1 and Cognitive impairment: Blocking the expression of FMRP impairs synaptic delivery and induces mild or profound behavioral disorders and learning defects [32], leading to FXS, mental retardation, premature ovarian failure, autism, Parkinson's disease, developmental delays, and cognitive deficits [33–35].